Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Rossi

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Breast Cancer Research and Treatment|July 29, 2025
Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective studyGuido Maria Giuffrè, Luisa Carbognin, Giovanna Masone Iacobucci, et al.
Minerva Endocrinology|December 11, 2024
Neuroendocrine neoplasms of the breast: a multicenter retrospective Italian studyRoberto Baldelli, Marta Franco, Valerio Renzelli, et al.
Communications Chemistry|November 4, 2025
From melanogenesis to melanin technologiesNoah Al-Shamery, Dauren Biyashev, Lluís Blancafort, et al.
Blood Advances|September 15, 2021
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?Alessandra Tedeschi, Anna Maria Frustaci, Francesca Romana Mauro, et al.
Science Signaling|October 11, 2018
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)Emiliano Cocco, F Javier Carmona, Pedram Razavi, et al.
Oncotarget|February 25, 2016
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcomePatrizia Vici, Laura Pizzuti, Isabella Sperduti, et al.
Haematologica|June 26, 2025
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practiceAnna Maria Frustaci, Andrea Galitzia, Mariano Lucignano, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Breast Cancer Research and Treatment|July 29, 2025
Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective studyGuido Maria Giuffrè, Luisa Carbognin, Giovanna Masone Iacobucci, et al.
Minerva Endocrinology|December 11, 2024
Neuroendocrine neoplasms of the breast: a multicenter retrospective Italian studyRoberto Baldelli, Marta Franco, Valerio Renzelli, et al.
Communications Chemistry|November 4, 2025
From melanogenesis to melanin technologiesNoah Al-Shamery, Dauren Biyashev, Lluís Blancafort, et al.
Blood Advances|September 15, 2021
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?Alessandra Tedeschi, Anna Maria Frustaci, Francesca Romana Mauro, et al.
Science Signaling|October 11, 2018
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)Emiliano Cocco, F Javier Carmona, Pedram Razavi, et al.
Oncotarget|February 25, 2016
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcomePatrizia Vici, Laura Pizzuti, Isabella Sperduti, et al.
Haematologica|June 26, 2025
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practiceAnna Maria Frustaci, Andrea Galitzia, Mariano Lucignano, et al.
Pageof 15